REFERENCES
- Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC. (2007). Evaluation and treatment of Chagas disease in the United States: a systematic review. Journal of the American Medical Association, 298, 2171–2181.
- Dantas RO, Deghaide NH, Donadi EA. (1999). Esophageal manometric and radiologic findings in asymptomatic subjects with Chagas’ disease. Journal of Clinical Gastroenterology, 28, 245–248.
- De Oliveira RB, Troncon LE, Dantas RO, Menghelli UG. (1998). Gastrointestinal manifestations of Chagas’ disease. American Journal of Gastroenterology, 93, 884–889.
- De Rezende JM, Moreira H. (1988). Chagasic megaesophagus and megacolon. Historical review and present concepts. Arqivos de Gastroenterologia,25 (SpecNo.)32–43.
- Flores-Chávez M, Fernández B, Puente S, Torres P, Rodríguez M, Monedero C, Cruz I, Gárate T, Cañavate C. (2008). Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. Clinical Infectious Diseases, 46, e44–e47.
- Herbella FA, Oliveira DR, del Grande JC. (2004). Are idiopathic and chagasic achalasia two different diseases? Digestive Diseases and Sciences, 49, 353–360.
- Iantorno G, Bassotti G, Kogan Z, Lumi CM, Cabanne AM, Fisogni S, Varrica LM, Bilder CR, Munoz JP, Liserre B, Morelli A, Villanacci V. (2007). The enteric nervous system in chagasic and idiopathic megacolon. American Journal of Surgical Pathology, 31, 460–468.
- Marin-Neto JA, Rassi A, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S. (2008). Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas’ cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). American Heart Journal, 156, 37–43.
- Meneghelli UG, Darezzo FM, Peria FM, Almeida FH, Rodrigues CM, Aprile LR, Dantas RO. (2005). Clinical, radiographic, and manometric evolution of esophageal involvement by Chagas’ disease. Dysphagia, 20, 40–45.
- Perez de Ayala A, Perez-Molina JA, Norman F, Lopez-Velez R. (2009). Chagasic cardiomyopathy in immigrants from Latin America to Spain. Emerging Infectious Diseases, 15, 607–608.
- Prata A. (2001). Clinical and epidemiological aspects of Chagas disease. Lancet Infectious Diseases, 1, 92–100.
- Rassi A, Rassi A, Marin-Neto JA. (2010). Chagas disease. Lancet, 375, 1388–1402.
- Schmunis GA. (2007). Epidemiology of Chagas disease in non-endemic countries: the role of international migration.. Memórias do Instituto Oswaldo Cruz, 102 (Suppl1), 75–85.
- Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A. (2006). Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Annals of Internal Medicine, 144, 724–734.